Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 11/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.68 |
| ▸ | MAPT | P10636 | 9/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.68 |
| ▸ | TP53 | P04637 | 7/20 | 0.68 |
| ▸ | RECQL | P46063 | 6/20 | 0.68 |
| ▸ | CDK2 | P24941 | 6/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.68 |
| ▸ | HPGD | P15428 | 5/20 | 0.68 |
| ▸ | LMNA | P02545 | 4/20 | 0.68 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.68 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.68 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.68 |
| ▸ | AMY1A | P0DUB6 | 3/20 | 0.68 |
| ▸ | APP | P05067 | 3/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7656375 | 0.89 | MEN1 (0.62) | MEN1KMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL10037939 | 0.88 | MEN1 (0.76) | MEN1KMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL25209431 | 0.86 | MAPT (0.57) | MEN1KMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL14697045 | 0.85 | TUBB4A (0.65) | MEN1KMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL14697047 | 0.85 | MAPT (0.74) | MEN1KMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL7659883 | 0.84 | MAPT (0.71) | MEN1KMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL12378689 | 0.84 | MEN1 (0.75) | MEN1KMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL10067898 | 0.82 | ADORA3 (0.71) | MEN1KMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL20496405 | 0.81 | CDK2 (0.59) | MEN1KMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL14259664 | 0.81 | TUBB4A (0.70) | MEN1KMT2AKDM4EMAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103929959-A | Neuroprotective polyphenol analogs | SALK INST FOR BIOLOGICAL STUDI | 2014-07-16 | — | — | CN | claimed |
| US-20140186329-A1 | POLYPHENOL ANALOGS TO TREAT ISCHEMIA | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2014-07-03 | — | — | US | claimed |
| US-20140186328-A1 | NEUROPROTECTIVE POLYPHENOL ANALOGS | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2014-07-03 | — | — | US | claimed |
| EP-2741609-A1 | NEUROPROTECTIVE POLYPHENOL ANALOGS | Salk Institute for Biological Studies (US) | 2014-06-18 | — | — | EP | claimed |
| WO-2013025484-A1 | POLYPHENOL ANALOGS TO TREAT ISCHEMIA | LAPCHAK PAUL A (US) | 2013-02-21 | — | — | WO | claimed |
| WO-2013025498-A1 | NEUROPROTECTIVE POLYPHENOL ANALOGS | SCHUBERT DAVID R (US) | 2013-02-21 | — | — | WO | claimed |
| EP-1109800-A1 | NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE | LG CHEMICAL LIMITED (KR) | 2001-06-27 | — | — | EP | claimed |
| WO-2000012496-A1 | NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE | LG CHEMICAL LTD. (KR) | 2000-03-09 | — | — | WO | claimed |
| US-9744164-B2 | Neuroprotective polyphenol analogs | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2017-08-29 | — | — | US | disclosed |
| US-9744164-B2 | Neuroprotective polyphenol analogs | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2017-08-29 | — | — | US | disclosed |
| US-9744164-B2 | Neuroprotective polyphenol analogs | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2017-08-29 | — | — | US | disclosed |
| US-20160206609-A1 | NEUROPROTECTIVE POLYPHENOL ANALOGS | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2016-07-21 | — | — | US | disclosed |
| US-20160206609-A1 | NEUROPROTECTIVE POLYPHENOL ANALOGS | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2016-07-21 | — | — | US | disclosed |
| US-20160206609-A1 | NEUROPROTECTIVE POLYPHENOL ANALOGS | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2016-07-21 | — | — | US | disclosed |
| US-20120016016-A1 | METHODS AND COMPOSITIONS FOR TREATING COMPLICATIONS OF DIABETES AND VASCULAR DISEASES USING FLAVONES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2012-01-19 | — | — | US | disclosed |
| US-20120016016-A1 | METHODS AND COMPOSITIONS FOR TREATING COMPLICATIONS OF DIABETES AND VASCULAR DISEASES USING FLAVONES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2012-01-19 | — | — | US | disclosed |
| WO-2010105253-A2 | METHODS AND COMPOSITIONS FOR TREATING COMPLICATIONS OF DIABETES AND VASCULAR DISEASES USING FLAVONES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2010-09-16 | — | — | WO | disclosed |
| US-6500846-B1 | 2-(4-CHLOROPHENYL)-7-METHOXYCHROMEN-4-ONE, AS CYCLIN-DEPENDENT KINASE INHIBITORS, USED AS ANTICARCINOGENIC AGENTS OR FOR PROPHYLAXIS OF NEURODEGENERATIVE DISEASE | LG CHEMICAL, LTD. (KR) | 2002-12-31 | — | — | US | disclosed |
| EP-1109800-A1 | NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE | LG CHEMICAL LIMITED (KR) | 2001-06-27 | — | — | EP | disclosed |
| WO-2000012496-A1 | NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE | LG CHEMICAL LTD. (KR) | 2000-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140186329-A1 | POLYPHENOL ANALOGS TO TREAT ISCHEMIA | GPX1, KEAP1, GPX4 | MEN1 4434/4885KMT2A 1403/4885KDM4E 1055/4885 |
| US-20140186328-A1 | NEUROPROTECTIVE POLYPHENOL ANALOGS | GSR, IAPP, GCLC | MEN1 2624/4885KMT2A 2552/4885KDM4E 3072/4885 |
| US-20120016016-A1 | METHODS AND COMPOSITIONS FOR TREATING COMPLICATIONS OF DIABETES AND VASCULAR DISEASES USING FLAVONES | SLC5A2, LIPG, TIE1 | MEN1 2979/4885KMT2A 3540/4885KDM4E 1794/4885 |
| US-20160206609-A1 | NEUROPROTECTIVE POLYPHENOL ANALOGS | GSR, IAPP, GCLC | MEN1 2624/4885KMT2A 2552/4885KDM4E 3072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.